News
Biocon's conosldidated net profit surged 154.24% to Rs 344.50 crore in Q4 FY25, compared with Rs 135.50 crore in Q4 FY24.
The global race for weight loss solutions has firmly arrived in India—bringing with it hope, hype, and a host of unanswered ...
AZ and Regeneron will collaborate on finding small-molecule drugs directed against ... Nordisk's once-daily injectable weight loss therapy Saxenda (liraglutide) has been a slow grower, but is ...
Medications such as liraglutide or semaglutide taken for weight loss also have the potential to reduce alcohol consumption by ...
The report runs an in-depth analysis of market trends, key players, and future opportunities. The generic drugs market comprises a range of drugs use ...
The latest attempt focuses on liraglutide, an older, once-daily injectable product in Novo Nordisk's GLP-1 agonist franchise sold as Victoza and Xultophy for diabetes and Saxenda for obesity.
Data Sources: PubMed was searched (to December 5, 2011) using the terms exenatide, liraglutide, albiglutide, and lixisenatide. The search was limited to studies published in English and conducted ...
Shaocheng Shen holds the team's unique molecule in solution. Credit: University of Miami A major challenge in molecular electronics is creating materials that can efficiently transport electrical ...
Participants who took liraglutide for 40 weeks showed improvements in some lung function measures, like the ability to forcefully exhale air and transfer gas from the air into their bloodstream. While ...
Single-molecule fluorescence experiments involve the study of individual fluorescent molecules, and can provide information that would be hidden in measurements involving a large number of molecules.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results